Vanda Pharmaceuticals
VNDA
#7922
Rank
NZ$0.62 B
Marketcap
NZ$10.34
Share price
4.01%
Change (1 day)
38.86%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -NZ$0.21 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.21 Billion. In 2024 the company made an earning of -NZ$70.55 Million a decrease over its 2023 earnings that were of -NZ$24.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.21 Billion194.5%
2024 -NZ$70.55 Million191.43%
2023 -NZ$24.21 Million-320.45%
2022 NZ$10.98 M-84.99%
2021 NZ$73.15 M54.8%
2020 NZ$47.25 M19.42%
2019 NZ$39.57 M4.93%
2018 NZ$37.71 M-228.6%
2017 -NZ$29.33 Million-8.98%
2016 -NZ$32.23 Million-53.79%
2015 -NZ$69.73 Million-30.18%
2014 -NZ$99.86 Million173.08%
2013 -NZ$36.57 Million-25.33%
2012 -NZ$48.98 Million163.61%
2011 -NZ$18.58 Million-221.15%
2010 NZ$15.33 M-124.53%
2009 -NZ$62.52 Million-29.44%
2008 -NZ$88.6 Million-36.2%
2007 -NZ$0.14 Billion21.81%
2006 -NZ$0.12 Billion170.55%
2005 -NZ$42.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.07 B-21,553.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.38 B-13,134.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$18.37 B-8,846.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$54.00 B-25,803.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.81 B-10,960.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.65 B-8,025.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-NZ$4.87 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA